Topical compositions and methods for treating pain

Abstract

Disclosed herein are topical compositions and methods for using the same to relieve pain in humans, such as pain associated with cancer, bone injuries, old age, and many other forms of pain. Specifically, the present compositions comprise an effective amount of acetone, a salicylate-based compound and an emollient. In addition, the present compositions further comprise one or more compounds including, but not limited to, terpenes and essential oils. The present compositions may be in the form of a liquid (preferably a slightly viscous liquid) or other forms including, but not limited to, salves, creams, gels, ointments or sprays.

I claim:  
     
         1 . A topical composition for the treatment of pain comprising by weight percent of the total weight of the composition: 
 a) about 1% to about 70% of a salicylate-based compound; and    b) about 1% to about 70% acetone.    
     
     
         2 . The topical composition of  claim 1 , wherein the composition comprises: 
 a) about 5% to about 30% of a salicylate-based compound; and    b) about 20% to about 60% acetone;    
     
     
         3 . The topical composition of  claim 2 , wherein the composition comprises: 
 (a) about 5% to about 20% of a salicylate-based compound; and    (b) about 15% to about 33% acetone;    
     
     
         4 . The topical composition of  claim 1 , wherein the composition comprises about 20% to about 40% menthol.  
     
     
         5 . The topical composition of  claim 1 , wherein the composition comprises alpha-pinene, beta-pinene, Eucalyptol, limonene, sabine, myrcene, menthene, alpha-phellandrene, linalool, isopulegol, junipene, alpha-terpinene, gamma-terpinene, camphene and water.  
     
     
         6 . The topical composition of  claim 1  wherein said salicylate-based compound is methyl-salicylate and said emollient is palm oil.  
     
     
         7 . The topical composition of  claim 1 , wherein said composition comprises: 
 a) about 15% to about 25% acetone;    b) about 0.5% to about 10% palm oil;    c) about 1% to about 30% alpha-pinene;    d) about 0.1% to about 5% beta-pinene;    e) about 0.3% to about 5% camphene;    f) about 0.3% to about 5% gamma-terpinene;    g) about 1.8% to about 5% limonene;    h) about 1.5% to about 5% sabinene;    i) about 0.4% to about 5% myrcene;    j) about 0.04% to about 5% menthene;    k) about 0.05% to about 5% alpha-phellandrene;    l) about 0.02% to about 5% linalool;    m) about 0.01% to about 5% isopulegol;    n) about 0.09% to about 5% junipene;    o) about 0.13% to about 5% alpha-terpinene;    p) about 5.6% to about 2% Eucalyptol;    q) about 15% to about 40% menthol;    r) about 5% to about 30% methyl salicylate; and    s) about 01.% to about 5% water.    
     
     
         8 . The topical composition of  claim 1 , wherein said composition comprises: 
 a) about 15% to about 35% acetone;    b) about 0.5% to about 10% of an emollient;    c) about 1% to about 30% alpha-pinene;    d) about 0.1% to about 5% beta-pinene;    e) about 0.1% to about 5% limonene;    f) about 0.1% to about 5% sabinene;    g) about 0.4% myrcene;    h) about 1% to about 20% Eucalyptol;    i) about 15% to about 40% menthol; and    j) about 5% to about 30% methyl salicylate.    
     
     
         9 . The topical composition of  claim 1 , wherein said composition comprises: 
 a) about 15% to about 35% acetone;    b) about 0.5% to about 10% of an emollient;    c) about 1% to about 30% alpha-pinene;    d) about 1% to about 20% Eucalyptol;    e) about 15% to about 40% menthol; and    f) about 5% to about 30% methyl salicylate.    
     
     
         10 . The topical composition of  claim 1 , wherein said composition comprises: 
 a) about 15% to about 35% acetone;    b) about 0.5% to about 10% of an emollient;    c) about 1% to about 30% alpha-pinene;    d) about 15% to about 40% menthol; and    e) about 5% to about 30% methyl salicylate.    
     
     
         11 . The topical compositions of  claim 1 , wherein the acetone, salicylate-based compound and emollient are commercial grade.  
     
     
         12 . The topical composition of  claim 1 , wherein the composition is in the form of a gel.  
     
     
         13 . The topical composition of  claim 1 , wherein the composition is in the form of an ointment.  
     
     
         14 . The topical composition of  claim 1 , wherein the composition is in the form of a cream.  
     
     
         15 . The topical composition of  claim 1 , wherein the composition is in the form of a salve.  
     
     
         16 . The topical composition of  claim 1 , wherein the composition is in the form of a lotion.  
     
     
         17 . The topical composition of  claim 1 , wherein the composition is in the form of a spray.  
     
     
         18 . The topical composition of  claim 1 , wherein the composition is in the form of an aerosol.  
     
     
         19 . A topical composition for treating pain associated with cancer wherein the composition comprises the composition of  claim 1 .  
     
     
         20 . A topical composition for treating neck pain comprising the composition of  claim 1.